Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T helper cell type 2 cytokines are a group of signaling proteins secreted by differentiated CD4+ T cells known as Th2 cells. The principal members include interleukin‑4 (IL‑4), IL‑5, IL‑9, IL‑10, IL‑13, and sometimes IL‑25. These molecules orchestrate the immune response against extracellular parasites such as helminths and play a central role in the development of allergic reactions by promoting antibody production—especially IgE—and activating eosinophils and basophils[1][4][5]. Overproduction or dysregulation of these cytokines is implicated in asthma, allergies, certain autoimmune conditions, and tissue fibrosis[1][2]. While individual Th2-associated interleukins can be considered therapeutic targets (e.g., anti–IL–5 therapies for asthma), the collective term "T helper cell type 2 cytokines" refers to a functional group rather than a single molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T helper cell type 2 cytokine (Th2 cytokine).